Literature DB >> 24434215

SnapShot: diffuse large B cell lymphoma.

Laura Pasqualucci1, Riccardo Dalla-Favera2.   

Abstract

Mesh:

Year:  2014        PMID: 24434215     DOI: 10.1016/j.ccr.2013.12.012

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


× No keyword cloud information.
  27 in total

1.  Efficacy and safety of rituximab combined with chemotherapy in the treatment of diffuse large B-cell lymphoma: a meta-analysis.

Authors:  Fanlu Meng; Diansheng Zhong; Linlin Zhang; Yi Shao; Qing Ma
Journal:  Int J Clin Exp Med       Date:  2015-10-15

Review 2.  PROTACs: great opportunities for academia and industry.

Authors:  Xiuyun Sun; Hongying Gao; Yiqing Yang; Ming He; Yue Wu; Yugang Song; Yan Tong; Yu Rao
Journal:  Signal Transduct Target Ther       Date:  2019-12-24

3.  An oxidative stress-based mechanism of doxorubicin cytotoxicity suggests new therapeutic strategies in ABC-DLBCL.

Authors:  Yun Mai; J Jessica Yu; Boris Bartholdy; Zijun Y Xu-Monette; Esther E Knapp; Fei Yuan; Hongshan Chen; B Belinda Ding; Zhihua Yao; Bhaskar Das; Yiyu Zou; Ken He Young; Samir Parekh; B Hilda Ye
Journal:  Blood       Date:  2016-10-13       Impact factor: 22.113

Review 4.  Precision therapy for lymphoma--current state and future directions.

Authors:  Andrew M Intlekofer; Anas Younes
Journal:  Nat Rev Clin Oncol       Date:  2014-08-19       Impact factor: 66.675

5.  Plasmablastic lymphoma phenotype is determined by genetic alterations in MYC and PRDM1.

Authors:  Santiago Montes-Moreno; Nerea Martinez-Magunacelaya; Tomás Zecchini-Barrese; Sonia Gonzalez de Villambrosía; Emma Linares; Tamara Ranchal; María Rodriguez-Pinilla; Ana Batlle; Laura Cereceda-Company; Jose Bernardo Revert-Arce; Carmen Almaraz; Miguel A Piris
Journal:  Mod Pathol       Date:  2016-09-30       Impact factor: 7.842

6.  Alterations of circulating follicular helper T cells and interleukin 21 in diffuse large B-cell lymphoma.

Authors:  Zhanshan Cha; Huijun Guo; Xiaohua Tu; Yan Zang; Haihui Gu; Haihan Song; Baohua Qian
Journal:  Tumour Biol       Date:  2014-05-03

Review 7.  Murine models of germinal center derived-lymphomas.

Authors:  Parham Ramezani-Rad; Robert C Rickert
Journal:  Curr Opin Immunol       Date:  2017-02-01       Impact factor: 7.486

8.  BCL6--regulated by AhR/ARNT and wild-type MEF2B--drives expression of germinal center markers MYBL1 and LMO2.

Authors:  Jie Ding; Wilhelm G Dirks; Stefan Ehrentraut; Robert Geffers; Roderick A F MacLeod; Stefan Nagel; Claudia Pommerenke; Julia Romani; Michaela Scherr; Lea A I Vaas; Margarete Zaborski; Hans G Drexler; Hilmar Quentmeier
Journal:  Haematologica       Date:  2015-03-13       Impact factor: 9.941

9.  Large-scale microarray profiling reveals four stages of immune escape in non-Hodgkin lymphomas.

Authors:  Marie Tosolini; Christelle Algans; Frédéric Pont; Bernard Ycart; Jean-Jacques Fournié
Journal:  Oncoimmunology       Date:  2016-05-19       Impact factor: 8.110

Review 10.  Emerging therapies provide new opportunities to reshape the multifaceted interactions between the immune system and lymphoma cells.

Authors:  M Pizzi; M Boi; F Bertoni; G Inghirami
Journal:  Leukemia       Date:  2016-06-08       Impact factor: 11.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.